Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Key Points PCCs for the management of major bleeding in patients on rivaroxaban or apixaban is an effective strategy in most cases. The thromboembolic complication rate in this setting is low and comparable with that of anticoagulation discontinuation without reversal.

authors

  • Majeed, Ammar
  • Ågren, Anna
  • Holmström, Margareta
  • Bruzelius, Maria
  • Chaireti, Roza
  • Odeberg, Jacob
  • Hempel, Eva-Lotta
  • Magnusson, Maria
  • Frisk, Tony
  • Schulman, Sam

publication date

  • October 12, 2017

published in